---
figid: PMC8634471__fphar-12-772510-g002
figtitle: Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets
  of Curcumin in Cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8634471
filename: fphar-12-772510-g002.jpg
figlink: /pmc/articles/PMC8634471/figure/F2/
number: F2
caption: 'Overview of curcumin-inhibition of RTKs and downstream MAPK, PI3K/Akt, JAK/STAT,
  and NF-κB pathway components. Abbreviations: RTK: Receptor tyrosine kinase; CUR:
  Curcumin, EGFR: Epidermal growth factor receptor, TLR4: Toll-like receptor 4, c-MET:
  Mesenchymal epithelial transition factor/Hepatocyte growth factor receptor; FGFR:
  Fibroblast growth factor receptor; IGF-1R: The insulin-like growth factor 1 receptor;
  PDGFR: Platelet-derived growth factor receptor; VEGFR: Vascular endothelial growth
  factor receptor; TKD: Tyrosine kinase domain; Rac: Ras-related C3 botulinum toxin
  substrate; ASK1: Apoptosis signal-regulating kinase 1; C/EBPα: CCAAT/enhancer-binding
  protein alpha; JNK: c-Jun N-terminal kinases; AP-1: Activator protein 1; Ras: Rat
  sarcoma virus protein; Raf: Rapidly accelerated fibrosarcoma protein; MEK: Mitogen-activated
  protein kinase kinase; ERK: Extracellular signal-regulated kinase; PPARγ: Peroxisome
  proliferator-activated receptor γ; COX2: Cyclooxygenase-2; PI3K: Phosphoinositide
  3-kinase; PTEN: Phosphatase and tensin homolog; Akt: Ak strain transforming; IKK:
  Inhibitor of nuclear factor kappa B kinase; NF-κB: nuclear factor kappa-light-chain-enhancer
  of activated B cells; FOXO: Forkhead box transcription factors; GSK3B: Glycogen
  synthase kinase 3 beta; Mtorc1: Mechanistic target of rapamycin complex 1; 4EBP1:
  Eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1; S6K: Ribosomal
  protein S6 kinase; HIF-α: Hypoxia-inducible factor alpha; JAK: Janus kinase; STAT:
  Signal transducer and activator of transcription. Created with BioRender.com.'
papertitle: Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic
  Targets of Curcumin in Cancer.
reftext: Sareshma Sudhesh Dev, et al. Front Pharmacol. 2021;12:772510.
year: '2021'
doi: 10.3389/fphar.2021.772510
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: curcumin | receptor tyrosine kinase | signaling pathway | polyphenol | combination
  therapy | tyrosine kinase inhibitor
automl_pathway: 0.9565484
figid_alias: PMC8634471__F2
figtype: Figure
redirect_from: /figures/PMC8634471__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8634471__fphar-12-772510-g002.html
  '@type': Dataset
  description: 'Overview of curcumin-inhibition of RTKs and downstream MAPK, PI3K/Akt,
    JAK/STAT, and NF-κB pathway components. Abbreviations: RTK: Receptor tyrosine
    kinase; CUR: Curcumin, EGFR: Epidermal growth factor receptor, TLR4: Toll-like
    receptor 4, c-MET: Mesenchymal epithelial transition factor/Hepatocyte growth
    factor receptor; FGFR: Fibroblast growth factor receptor; IGF-1R: The insulin-like
    growth factor 1 receptor; PDGFR: Platelet-derived growth factor receptor; VEGFR:
    Vascular endothelial growth factor receptor; TKD: Tyrosine kinase domain; Rac:
    Ras-related C3 botulinum toxin substrate; ASK1: Apoptosis signal-regulating kinase
    1; C/EBPα: CCAAT/enhancer-binding protein alpha; JNK: c-Jun N-terminal kinases;
    AP-1: Activator protein 1; Ras: Rat sarcoma virus protein; Raf: Rapidly accelerated
    fibrosarcoma protein; MEK: Mitogen-activated protein kinase kinase; ERK: Extracellular
    signal-regulated kinase; PPARγ: Peroxisome proliferator-activated receptor γ;
    COX2: Cyclooxygenase-2; PI3K: Phosphoinositide 3-kinase; PTEN: Phosphatase and
    tensin homolog; Akt: Ak strain transforming; IKK: Inhibitor of nuclear factor
    kappa B kinase; NF-κB: nuclear factor kappa-light-chain-enhancer of activated
    B cells; FOXO: Forkhead box transcription factors; GSK3B: Glycogen synthase kinase
    3 beta; Mtorc1: Mechanistic target of rapamycin complex 1; 4EBP1: Eukaryotic translation
    initiation factor 4E (eIF4E)-binding protein 1; S6K: Ribosomal protein S6 kinase;
    HIF-α: Hypoxia-inducible factor alpha; JAK: Janus kinase; STAT: Signal transducer
    and activator of transcription. Created with BioRender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cur
  - Cu-3
  - Egfr
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Mekk1
  - Ask1
  - hep
  - lic
  - Mkk4
  - bsk
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Toll-4
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - rl
  - AP-1gamma
  - Jra
  - kay
  - Tie
  - InR
  - hh
  - COX2
  - IKKepsilon
  - key
  - IKKbeta
  - btl
  - htl
  - rv
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dif
  - dl
  - Rel
  - sgg
  - Axn
  - gskt
  - foxo
  - Pten
  - Crtc
  - Thor
  - sima
  - Stat92E
  - S6k
  - hop
  - Pvr
  - tkd
  - EGFR
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - MAP3K1
  - MAP3K5
  - MAP2K7
  - MAP2K3
  - MAP2K4
  - MAP2K6
  - CEBPA
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TLR4
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - MAPK3
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - MET
  - PTGS2
  - MTCO2P12
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - AKT2
  - AKT3
  - GSK3B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - IGF1R
  - PTEN
  - MTOR
  - RPTOR
  - EIF4EBP1
  - HIF1A
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PDGFRB
  - PDGFRA
  - RPS6KB1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KDR
  - FLT1
  - FLT4
---
